Efficacy and safety of electroacupuncture for the treatment of chronic insomnia comorbid pain

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400082661

Enrollment

Unknown

Registered

2024-04-03

Start date

2023-09-20

Completion date

Unknown

Last updated

2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomnia

Interventions

The treatment group:Baihui, Sishencong, Shenmen, Neiguan, Hegu, Zusanli, Local Ashi point (according to the pain site, Select 1-3 points) (with reference to the traditional Chinese medicine planning

The control group:Acupuncture Baihui, Sishencong, Shenmen, Neiguan, Hegu, Zusanli, local A is beside the non-meridian and non-collateral points Acupuncture point. The needle selection, acupuncture ma

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) meeting the diagnostic criteria of chronic insomnia and chronic pain; (2) PSQI=7; VAS 3 or more points; (3) 18 years old =65 years old; (4) Able to cooperate with the completion of various scale assessment and sample collection; (5) Sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with serious physical diseases; (2) Mini scale interview indicated mental disorders; (3) Patients with substance use disorders (including addiction or abuse of alcohol, tobacco, caffeine, sedatives, psychoactive drugs and other substances); (4) SQ =5; SBQ 3 or more points; IRLS 10 or more points; (5) The use of antidepressant and other psychotropic drugs (fluoxetine within 4 weeks), analgesia and auxiliary analgesic drugs in the past 2 weeks; (6) Combined use of any drugs to improve sleep and pain (including traditional Chinese medicine or health products with calming effect) and treatment (including other non-drug therapy of traditional Chinese medicine, psychological therapy and physical therapy); (7) Suffering from malignant tumors and severe diseases of the heart, liver, kidney and nervous system; (8) Women who are pregnant, lactating or preparing for pregnancy; (9) GAD-7 score =10; PHQ - 9 or 10 points;

Design outcomes

Primary

Measure	Time frame
Pittsburgh sleep quality index;Simplified McGill Pain Questionnaire Short-Form;	—

Secondary

Measure	Time frame
Insomnia Severity Index;Numerical rating scale;Patient Health Questionnaire-9;Generalized Anxiety Disorder;	—

Countries

China

Contacts

Public ContactJia Xing

East Hospital of Beijing University of Chinese Medicine

13283480122@163.com+86 138 1068 0063

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026